Germany Coal Fund Drops Evonik Veto Floor, Opening Path to BASF Takeover

Germany's RAG Foundation, which owns ~44% of Evonik, removed its 25.1% veto floor, allowing potential sale of its stake. BASF is exploring a takeover. Evonik's dividend policy change and RAG's financial needs are key factors. BASF aims to expand its specialty chemicals portfolio. Regulatory scrutiny expected.

Original reporting
Published Sep 30, 2026, 6:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 11:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Germany Coal Fund Drops Evonik Veto Floor, Opening Path to BASF Takeover — source image
Decision brief

The 30-second read

High
01

Why it matters

The removal of the 25.1% blocking minority removes a key obstacle to a BASF takeover, reshaping the M&A landscape in European chemicals.

02

Market read

The news clears a major governance hurdle, potentially triggering a high-profile European chemical merger.

03

What to watch

The RAG Foundation's exchangeable bonds may limit the actual cash available for a takeover.

Relevance 8/10Novelty 8/10Timing: today

Background

The RAG Foundation, a coal-legacy fund, has been a cornerstone shareholder of Evonik for two decades.

Market effects

The chemicals sector may see consolidation pressure, with peers reassessing valuations.

European markets could react to heightened M&A activity in the chemical industry.

Potential creation of a larger European chemical champion may affect global supply dynamics.

Counterpoint

The deal could stall if regulatory scrutiny intensifies, keeping Evonik's share price stable.

Key entities

  • RAG Foundation

    Coal-legacy fund holding ~44% of Evonik.

  • BASF SE

    World's largest chemical company, exploring Evonik acquisition.

  • Evonik Industries AG

    German specialty chemicals group, target of potential takeover.

Related articles

HighAI 8/10

Evonik's losses shrink as core earnings surge 40%

Evonik Industries reported a narrower net loss of €53M in Q3, down from €106M a year ago, with net sales up 13% to €3.83B. Adjusted EBITDA surged 40% to €629M. The company expects full-year adjusted EBITDA at the upper end of its €2B-€2.2B range.